Back to Search Start Over

A cluster of type I interferon-regulated genes associates with disease activity and prognosis in patients with IgA nephropathy.

Authors :
Qu S
Gan T
Wang YN
Qi YY
Zhang YM
Berthier CC
Liu LJ
Shi SF
Lv JC
Zhang H
Zhou XJ
Source :
International immunopharmacology [Int Immunopharmacol] 2024 Apr 20; Vol. 131, pp. 111920. Date of Electronic Publication: 2024 Mar 23.
Publication Year :
2024

Abstract

The exact pathogenesis of IgA nephropathy (IgAN) is complex and so far, not well defined. Since it has been shown that microbial infections could induce high levels of type I interferon (IFN-I) and there is an evident link between mucosal infection and gross hematuria in IgAN, we hypothesized that IFN-I may play a role in the pathogenic process. In this study, we investigated the type I interferon status in IgAN based on the expression of 17 IFN-regulated genes (IRGs) in whole blood from 59 IgAN patients in a cross-sectional study, of which 34 patients followed longitudinally. Analysis of the IFN-score showed that there was a significant elevated IFN-score in the IgAN patients compared with healthy controls (n = 28, p = 9.80 × 10 <superscript>-3</superscript> ), and we observed an elevated IFN-score in the group with less tubular atrophy/interstitial fibrosis (p = 1.07 × 10 <superscript>-2</superscript> ) and with a lower proportion of mesangial hypercellularity (p = 1.23 × 10 <superscript>-2</superscript> ). In the longitudinal analysis, Cox regression analysis revealed that a higher IFN level was associated with a better renal outcome in IgAN after adjustments for gender and age (hazard ratio, 0.90; 95 % confidence interval, 0.81 to 0.97; p = 4.20 × 10 <superscript>-2</superscript> ). In conclusion, our finding suggested that IFN score may represent a novel type of biomarker in IgAN, which requires further exploration on its mechanism and therapeutic targeting.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024 Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1878-1705
Volume :
131
Database :
MEDLINE
Journal :
International immunopharmacology
Publication Type :
Academic Journal
Accession number :
38522142
Full Text :
https://doi.org/10.1016/j.intimp.2024.111920